ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,627, issued on May 19, was assigned to INNOVENT BIOLOGICS (SUZHOU) Co. LTD. (Suzhou, China) and BEIJING HANMI PAHRMACEUTICAL Co. LTD. (Beijing).
"Formulation comprising anti-PD-1/HER2 bispecific antibody, method for preparing same and use thereof" was invented by Yanghan Liu (Suzhou, China), Yidong Ma (Suzhou, China), Yinjue Wang (Suzhou, China) and Kaisong Zhou (Suzhou, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to formulations comprising an anti-PD-1/HER2 bispecific antibody, and in particular to a pharmaceutical formulation comprising the anti-PD-1/HER2 bispecific antibody, a buffer, a stabilizer and a surfa...